Aequus Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was CAD 0.098409 million compared to CAD 0.346494 million a year ago. Net loss was CAD 0.700875 million compared to CAD 0.77211 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, revenue was CAD 0.19066 million compared to CAD 0.648774 million a year ago. Net loss was CAD 1.45 million compared to CAD 1.69 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.